Phase 2 Endometriosis Trial, Recruiting (NCT05480995)

Phase 2 Endometriosis Trial, Recruiting NCT05480995 Sponsor: University of North Carolina, Chapel Hill Condition: Endometriosis

Printed from Voxsanity (voxsanity.com.au) — NCT05480995 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometriosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You are a woman of childbearing age (between 18 and 55 years old)
Your doctor suspects you have endometriosis based on symptoms you are experiencing (this may include cysts on the ovaries related to endometriosis)
You are already scheduled for a keyhole surgical procedure to treat your condition and have not used hormone treatments for at least two menstrual cycles before the procedure
You are able to understand and agree to take part in the study by giving your consent

Who may not be able to join:

You are male
You currently live in a care facility such as a nursing home, or you are incarcerated
You have a known history of breast, ovarian, or uterine cancer
You are currently pregnant or breastfeeding
You have been taking certain hormone-based medications (such as progestin or monthly hormone-blocking injections) in the recent weeks, or you are unable to stop taking these medications (confirm with trial site for exact timing details)
You have a known allergy to the dye used in MRI scans (called gadolinium), or your kidneys are not functioning well enough to safely process this dye

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Jorge Oldan, MD, University of North Carolina, Chapel Hill

Phone: 919-843-3670

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05480995

Sponsor: University of North Carolina, Chapel Hill

Phase: Phase 2

Status: Recruiting

Condition: Endometriosis

Trial contact: 919-843-3670

More information: https://clinicaltrials.gov/study/NCT05480995

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You are a woman of childbearing age (between 18 and 55 years old)
Your doctor suspects you have endometriosis based on symptoms you are experiencing (this may include cysts on the ovaries related to endometriosis)
You are already scheduled for a keyhole surgical procedure to treat your condition and have not used hormone treatments for at least two menstrual cycles before the procedure
You are able to understand and agree to take part in the study by giving your consent

Who may not be able to join:

You are male
You currently live in a care facility such as a nursing home, or you are incarcerated
You have a known history of breast, ovarian, or uterine cancer
You are currently pregnant or breastfeeding
You have been taking certain hormone-based medications (such as progestin or monthly hormone-blocking injections) in the recent weeks, or you are unable to stop taking these medications (confirm with trial site for exact timing details)
You have a known allergy to the dye used in MRI scans (called gadolinium), or your kidneys are not functioning well enough to safely process this dye

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

University of North Carolina, Chapel Hill

Registry

ClinicalTrials.gov

Start date

17 January 2023

Est. completion

1 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Sensitivity of 18F-fluorofuranylnorprogesterone (FFNP) PET/MR for evaluating endometriosis; Specificity of 18F-fluorofuranylnorprogesterone (FFNP) PET/MR for evaluating endometriosis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov